Sanofi Investing €700 Million Ahead Of Launches
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi is ramping up for several product launches in the next 12 months, including a next-generation basal insulin Toujeo, Lemtrada for multiple sclerosis, Cerdelga for Gaucher’s disease and Praluent for high cholesterol.